期刊文献+

皖南地区74例嗜麦芽窄食单胞菌的分布及耐药分析 被引量:4

Analysis of 74 Strains of Stenotrophomonas Maltophilia in Southern Regiongs of Anhui
下载PDF
导出
摘要 目的了解皖南地区嗜麦芽窄食单胞菌的分布情况及耐药性,为临床治疗提供参考。方法对皖南地区2007~2009年检测出的嗜麦芽窄食单胞菌进行回顾性分析。结果患者年龄分布以60岁以上为主,感染部位以肺部为主,感染科室以干部内科为主;74例标本药敏结果耐药率从高到低依次为头孢噻肟87.83%、头孢吡肟64.87%、头孢他啶52.70%、替卡西林/克拉维酸41.89%、氯霉素24.32%、头孢哌酮/舒巴坦21.62%、复方新诺明21.62%、左旋氧氟沙星14.86%、米诺环素13.51%。结论作为条件致病菌,嗜麦芽窄食单胞菌的感染已呈增加趋势,应引起临床足够重视,药物治疗应首选四环素类、喹诺酮类和磺胺类。 Objective To investigate the distribution and antibiotic resistance of Stenotrophomonas maltophilia (SMA) in southern regions of Anhui so as to provide reference for clinical medication. Method To review the SMA, which had been isolated from 2007 to 2009 in southern regions. Results The predominant susceptible ages was more than 60, the main infected part was pulmonary and the main distribution was cadre medicine ;the resistant rates of 74 specimens to cefotaxime, cefepime, ceftazidime, ticarcillin/clavulanic, chloramphenicol, cefoperazone/sulbactam, sulfamethoxazole, lev- ofloxacin and minocycline were 87.83%,64.87%,52.70%,41.89%,24.32%,21.62%,21.62%,14.86% and 13.51% re- spectively. Conclusion We should take great importance to the increasing infected rate of Stenortophomonas maltophilia as one of the most important opportunity bacteria of hospital. Tetracycline quinolones and sulfa were the optimal choice for antibiotic therapy.
出处 《临床输血与检验》 CAS 2012年第3期221-223,共3页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 嗜麦芽窄食单胞菌 耐药性 Stenotrophomonas maltophilia Drug-resistance
  • 相关文献

参考文献6

二级参考文献54

共引文献79

同被引文献49

  • 1李家泰,李耘,齐慧敏,代表中国细菌耐药监测研究组.2002—2003年中国革兰阴性细菌耐药性监测研究[J].中华检验医学杂志,2005,28(1):19-29. 被引量:296
  • 2方小龙,陈群.嗜麦芽窄食单胞菌感染与控制的研究进展[J].广东医学院学报,2007,25(1):80-82. 被引量:6
  • 3陈福仙,宋瑞红,唐群力,沈爱娣.102例老年非发酵革兰阴性杆菌院内获得性肺炎的临床分析[J].老年医学与保健,2007,13(4):237-239. 被引量:3
  • 4邓笑伟,刘长庭,李天智,王俊锋,粱立武,黄燕萍,莫晨.嗜麦芽寡养单胞菌中Ⅱ类整合酶基因的发现及意义[J].中华医院感染学杂志,2007,17(9):1061-1063. 被引量:19
  • 5Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement M100-S22 [S]. Wayne Pennsylvania: Clinical and Laboratory Standards Institute, 2012: 100.
  • 6Valdezate S, Vindel A, Loza E,et al.Antimicrobial susceptibilities of unique Stenotrophomonas maltophilia clinical strains [J]. Antimicrob Agents Chemother, 2001,45:1581-1584.
  • 7Church H, Lloyd T, Peirano G, et al. Antimicrobial susceptibility and combination testing of invasive Stenotrophomonas mahophilia isolates[J]. Scand J Infect Dis, 2012, 45:265-270.
  • 8Hu L F,Chang X,Ye Y. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron[J].Int JAntirmicrob Agents,2011,(3):230-234.
  • 9Neela V,Rankouhi S Z,Belkum A. Stenotrophomonas maltophilia in Malaysia:molecular epidemiology and trimethoprim-sulfamethoxazole resistance[J].{H}International Journal of Infectious Diseases,2012,(8):e603-e607.
  • 10A1-Jasser A M. Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole:an increasing problem[J].{H}Annals of Clinical Microbiology and Antimicrobials,2006.23.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部